ESR1 and breast cancer: The prognostic role of body mass index has been previously assessed on the outcome of a consecutive series of women treated at our institution (the European Institute of Oncology (IEO), Milan, Italy) for an aggressive form [estrogen receptor/human epidermal growth factor receptor 2 (ER-/HER2)-positive] of breast cancer.